Torrent Pharmaceuticals Limited, one of India’s leading pharmaceutical companies, has strongly refuted claims surrounding the quality of its popular product Shelcal 500. In a statement released today, Torrent Pharmaceuticals addressed reports from the Central Drugs Standard Control Organization (CDSCO) regarding a batch of Shelcal 500 tablets allegedly failing a quality test. Torrent Pharmaceuticals made it […]
Torrent Pharmaceuticals Limited has secured a non-exclusive patent licensing agreement with Takeda Pharmaceutical Company Limited to commercialize Vonoprazan, a novel potassium-competitive acid blocker (P-CAB), in India. This agreement marks a significant step forward in the treatment of acid-related disorders like Gastroesophageal Reflux Disease (GERD) within the Indian market. Torrent to Launch Vonoprazan Under the Trademark […]
Torrent Pharmaceuticals Limited and Zydus Lifesciences Limited announced a significant licensing and supply agreement to co-market Saroglitazar Mg, a drug for treating Non-Alcoholic Steato Hepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD) in India. As the only drug approved in the country for these liver disorders, Saroglitazar Magnesium is poised to play a crucial role […]
Torrent Pharmaceuticals, a key player in the pharmaceutical landscape, has publicized its financial figures for Q1 FY24, showcasing a solid 10% revenue growth, touching Rs. 2,591 crores. Additionally, its Operational EBITDA has witnessed an 11% surge, amounting to Rs. 791 crores. Financial Highlights of Q1 FY24 With an impressive gross margin standing at 74.9% and […]
Torrent Pharmaceuticals said that it has wrapped up the previously announced INR 2,000 crores acquisition of Curatio Healthcare (I) Private Limited, a cosmetic dermatology company. Announced in late September 2022, the deal is expected to help the Indian pharmaceutical firm bolster its presence in the dermatology segment. Curatio Healthcare gives 600 medical representatives (MRs) and […]
Indian pharma company Torrent Pharmaceuticals has agreed to acquire cosmetic dermatology company Curatio Healthcare (I) Private Limited for INR 2,000 crores, in a move to strengthen its presence in the dermatology segment. The consideration consists of INR 115 crores of cash and cash equivalents in the acquired business, which gives an enterprise value of INR […]
Torrent Pharmaceuticals has agreed to acquire the Styptovit-E, Finast, Finast-T, and Dynapress brands from Dr. Reddy’s Laboratories for an undisclosed price. Styptovit-E is a gynecology product, which has an estimated market size of around INR 500 crores as per AIOCD data set. The gynecology product is expected to further bolster the presence of Torrent Pharmaceuticals […]
Torrent Pharmaceuticals has entered into a licensing agreement with Medicine Patent Pool (MPP) for manufacturing and commercializing the generic version of Pfizer’s oral Covid-19 treatment. Pfizer’s oral Covid-19 treatment is made up of PAXLOVID (nirmatrelvir), which inhibits a SARS-CoV-2 protein to prevent the SARSCoV-2 virus from replicating and ritonavir, which slows down the breakdown of […]
Five Indian pharma companies – Cipla, Dr. Reddy’s Laboratories, Emcure Pharmaceuticals, Sun Pharmaceutical Industries, and Torrent Pharmaceuticals will join forces to undertake a clinical trial of Molnupiravir, an investigational oral anti-viral drug for the treatment of mild Covid-19 in India. The clinical trial of Molnupiravir will be in an outpatient setting. Molnupiravir is being developed […]